No Data
No Data
Can Amgen (AMGN) Keep the Beat Streak Alive in Q2 Earnings?
Oppenheimer Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $380
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
10 Health Care Stocks Whale Activity In Today's Session
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?